Neoadjuvant Folfiri+Bevacizumab in resectable liver metastases from CRC: results and comparison of PET/CT scan vs RECIST in predicting outcome. (2019) - Belli, A.; Palaia, R.; Albino, V.; Amore, A.; Piccirillo, M.; Leongito, M.; Nasti, G.; Granata, V.; Petrillo, A.; Lastoria, S.; Izzo, F.